Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
GLIALIA (ITALY)
Ingredients per tablet:
Palmitoylethanolamide 400 mg, Luteolin in co-ultramicronized form (Ultramicrocomposite PEALUT®) 40 mg, Mixture, excipients (Microcrystalline cellulose, Magnesium stearate, Vegetable Polysorbate, Polyethylene glycol/Macrogol (E1521), Sodium Croscarmellose, Povidone, Polyvinyl alcohol, Colloidal anhydrous silica, Talc, Yellow iron oxide (E172), Titanium dioxide (E171)). 225.00 mg
Palmitoylethanolamide 400 mg, Luteolin in co-ultramicronized form (Ultramicrocomposite PEALUT®) 40 mg, Mixture, excipients (Microcrystalline cellulose, Magnesium stearate, Vegetable Polysorbate, Polyethylene glycol/Macrogol (E1521), Sodium Croscarmellose, Povidone, Polyvinyl alcohol, Colloidal anhydrous silica, Talc, Yellow iron oxide (E172), Titanium dioxide (E171)). 225.00 mg
The drug Glialia is used for:
- consequences of ischemic cerebral circulation disorders (TIA);
- post-stroke conditions based on ischemia;
- post-traumatic CNS conditions;
- cognitive impairments;
- early-stage dementia;
- early-stage Parkinson's disease;
- inflammatory demyelinating diseases;
- motor neuron diseases.
It is recommended to take 2 tablets per day (one in the morning and one in the evening) for long cycles of 6 months, with the possibility of repeating if necessary.
Use under medical supervision.
Not recommended for use during pregnancy.
60 coated tablets of 400 mg + 40 mg.
- consequences of ischemic cerebral circulation disorders (TIA);
- post-stroke conditions based on ischemia;
- post-traumatic CNS conditions;
- cognitive impairments;
- early-stage dementia;
- early-stage Parkinson's disease;
- inflammatory demyelinating diseases;
- motor neuron diseases.
It is recommended to take 2 tablets per day (one in the morning and one in the evening) for long cycles of 6 months, with the possibility of repeating if necessary.
Use under medical supervision.
Not recommended for use during pregnancy.
60 coated tablets of 400 mg + 40 mg.
